Prescription drug · ANDA
Carbidopa And Levodopa NDC 67046-1668
Carbidopa 25 mg/1; Levodopa 250 mg/1 · Tablet · Oral · Coupler LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 67046-1668-3 | 6704616680367046166803 | 30 TABLET in 1 BLISTER PACK (67046-1668-3)Marketed from Apr 22, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Carbidopa And Levodopa
- Generic name (nonproprietary)
- carbidopa and levodopa
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Coupler LLCNDC labeler code 67046
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 218939
- Marketing start
- Listing expires
- Other FDA classes
- Aromatic (Chemical structure)
- Identifiers
- Product ID 67046-1668_500f063b-fab2-993b-e063-6394a90aa366SPL ID 500f063b-fab2-993b-e063-6394a90aa366SPL set ID 500f0cdb-10e1-9545-e063-6394a90a3ad1RxCUI 197445UNII MNX7R8C5VO, 46627O600J
- Pharmacologic class
- Aromatic Amino Acid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N467046166803followed by a unit qualifier and the quantityPackage 67046-1668-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Carbidopa and levodopa tablets are indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. Carbidopa allows patients treated for Parkinson's disease to use much lower doses of levodopa. Some patients who responded poorly to levodopa have improved on carbidopa and levodopa tablets. This is most likely due to decreased peripheral decarboxylation of levodopa caused by administration of carbidopa rather than by a primary effect of carbidopa on the nervous system. Carbidopa has not been shown to enhance the intrinsic efficacy of levodopa. Carbidopa …
Excerpt only. Read the full label for complete information.
About NDC 67046-1668
- What is NDC 67046-1668?
- 67046-1668 is the product NDC for Carbidopa And Levodopa, Carbidopa 25 mg/1; Levodopa 250 mg/1 tablet, listed with the FDA by Coupler LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Carbidopa And Levodopa.
- What is the active ingredient?
- Carbidopa, Levodopa.
- Who is the labeler?
- Coupler LLC, NDC labeler code 67046. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Carbidopa And Levodopa?
- 97 other product NDCs are listed under this name. See all Carbidopa And Levodopa NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Carbidopa And Levodopa products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Carbidopa and Levodopa | Carbidopa 25 mg/1; Levodopa 250 mg/1 | TabletOral | Coupler LLC | 67046-1689 | 67046-1689-03 |
| Carbidopa and Levodopa | Carbidopa 25 mg/1; Levodopa 100 mg/1 | TabletOral | AvPAK | 50268-202 | 50268-0202-15 |
| Carbidopa and Levodopa | Carbidopa 48.75 mg/1; Levodopa 195 mg/1 | Capsule, Extended releaseOral | REMEDYREPACK INC. | 70518-4621 | 70518-4621-00 |
| Carbidopa and Levodopa | Carbidopa 23.75 mg/1; Levodopa 95 mg/1 | Capsule, Extended releaseOral | REMEDYREPACK INC. | 70518-4618 | 70518-4618-00 |
| Carbidopa and Levodopa | Carbidopa 25 mg/1; Levodopa 250 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4620 | 70518-4620-00 |
| Carbidopa and Levodopa | Carbidopa 36.25 mg/1; Levodopa 145 mg/1 | Capsule, Extended releaseOral | REMEDYREPACK INC. | 70518-4630 | 70518-4630-00 |
| Carbidopa and Levodopa | Carbidopa 61.25 mg/1; Levodopa 245 mg/1 | Capsule, Extended releaseOral | REMEDYREPACK INC. | 70518-4610 | 70518-4610-00 |
| Carbidopa and Levodopa | Carbidopa hydrate 25 mg/1; Levodopa 100 mg/1 | Tablet, Extended releaseOral | Safecor Health, LLC | 48433-015 | 48433-0015-20 |
| Carbidopa and Levodopa | Carbidopa hydrate 50 mg/1; Levodopa 200 mg/1 | Tablet, Extended releaseOral | Safecor Health, LLC | 48433-016 | 48433-0016-20 |
| Carbidopa And Levodopa | Carbidopa 25 mg/1; Levodopa 100 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 53401-020 | 53401-0020-6053401-0020-80 |
Other NDCs under ANDA 218939
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Carbidopa And Levodopa | Carbidopa 10 mg/1; Levodopa 100 mg/1 | TabletOral | Camber Pharmaceuticals, Inc. | 31722-381 |
| Carbidopa And Levodopa | Carbidopa 25 mg/1; Levodopa 100 mg/1 | TabletOral | Camber Pharmaceuticals, Inc. | 31722-382 |
| Carbidopa And Levodopa | Carbidopa 25 mg/1; Levodopa 250 mg/1 | TabletOral | Camber Pharmaceuticals, Inc. | 31722-383 |
| Carbidopa And Levodopa | Carbidopa 25 mg/1; Levodopa 100 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 53401-020 |
| Carbidopa And Levodopa | Carbidopa 10 mg/1; Levodopa 100 mg/1 | TabletOral | XLCare Pharmaceuticals, Inc. | 72865-361 |
| Carbidopa And Levodopa | Carbidopa 25 mg/1; Levodopa 100 mg/1 | TabletOral | XLCare Pharmaceuticals, Inc. | 72865-362 |
| Carbidopa And Levodopa | Carbidopa 25 mg/1; Levodopa 250 mg/1 | TabletOral | XLCare Pharmaceuticals, Inc. | 72865-363 |